Novo Integrated Sciences Inc. (NVOS) is priced at $2.43 after the most recent trading session. At the very opening of the session, the stock price was $2.66 and reached a high price of $2.66, prior to closing the session it reached the value of $2.74. The stock touched a low price of $2.21.
Recently in News on April 9, 2021, Novo Integrated Sciences Announces Pricing of $8.0 Million Registered Direct Offering. Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo Integrated Sciences”), a U.S.-based provider of multidisciplinary primary healthcare in Canada, today announced it has entered into a securities purchase agreement with certain accredited institutional investors to purchase approximately $8.0 million of its common stock in a registered direct offering and warrants to purchase common stock in a concurrent private placement. The combined purchase price for one share of common stock and each warrant will be $3.35. You can read further details here
Novo Integrated Sciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $14.98 on 02/24/21, with the lowest value was $2.00 for the same time period, recorded on 02/02/21.
Novo Integrated Sciences Inc. (NVOS) full year performance was -39.25%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Novo Integrated Sciences Inc. shares are logging -83.78% during the 52-week period from high price, and 150.52% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.97 and $14.98.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1118238 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Novo Integrated Sciences Inc. (NVOS) recorded performance in the market was -42.14%, having the revenues showcasing -30.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 76.18M, as it employees total of 73 workers.
Novo Integrated Sciences Inc. (NVOS) in the eye of market guru’s
During the last month, 0 analysts gave the Novo Integrated Sciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.12, with a change in the price was noted -0.87. In a similar fashion, Novo Integrated Sciences Inc. posted a movement of -26.36% for the period of last 100 days, recording 443,651 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NVOS is recording 0.05 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.03.
Novo Integrated Sciences Inc. (NVOS): Stocks Technical analysis and Trends
Raw Stochastic average of Novo Integrated Sciences Inc. in the period of last 50 days is set at 3.31%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 7.26%. In the last 20 days, the company’s Stochastic %K was 6.75% and its Stochastic %D was recorded 7.53%.
If we look into the earlier routines of Novo Integrated Sciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -42.14%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -36.05%, alongside a downfall of -39.25% for the period of the last 12 months. The shares increased approximately by -32.69% in the 7-day charts and went up by -40.44% in the period of the last 30 days. Common stock shares were lifted by -30.57% during last recorded quarter.